
STAT Plus: Peter Bach’s latest crazy idea: Give up on biosimilars. Regulate drug prices instead
FORTUNE BRAINSTORM HEALTH 2016
The health policy expert thinks that biosimilars, the would-be cheaper alternatives to expensive biologic drugs, are a lost cause. Not everyone agrees.


No hay comentarios:
Publicar un comentario